TRIFLUOPERAZINE 5 MG TABLET
For 30 tablets
Pharmacies pay
$25.80 filed
30 × $0.86 per EA
CMS NADAC · nadac-national-average-drug-acquisition-cost-20261014.csv · eff. 2026-09-23 · as of 2026-10-14 · retrieved 2026-10-17
Medicare Part D paid
$25.05 filed
30 × $0.83507 per EA, Part D average
Medicare's price is not your price.
Medicare Part D · DSD_PTD_RY26_P04_V10_DY24_BGM.csv · eff. 2024-01-01 to 2024-12-31 · as of 2026-06-25 · retrieved 2026-10-18
The spread
0.97× estimated
Medicare paid about what pharmacies pay.
Part D averages every strength and form sold under “Trifluoperazine HCl” into one figure, so it is not specific to this NDC.
OpenBill calculation · DSD_PTD_RY26_P04_V10_DY24_BGM.csv + nadac-national-average-drug-acquisition-cost-20261014.csv · NADAC eff. 2026-09-23 (file of 2026-10-14, retrieved 2026-10-17) · Part D 2024-01-01 to 2024-12-31 (file of 2026-06-25, retrieved 2026-10-18)
Cost-plus estimate
$34.67 estimated
$25.80 + $3.87 (15%) + $5.00 fee per fill = $34.67
This is a model, not a price any pharmacy quoted. Shipping is not included. How it is worked out
OpenBill calculation · nadac-national-average-drug-acquisition-cost-20261014.csv · NADAC eff. 2026-09-23 (file of 2026-10-14, retrieved 2026-10-17)
Open the interactive card Change the quantity, type what you were charged, and see every record in full.
What it is
TRIFLUOPERAZINE 5 MG TABLET is how the CMS NADAC file names this product. The FDA NDC Directory lists it as trifluoperazine hydrochloride.
FDA gives its dosage form as tablet, film coated and its route as oral.
Its labelers, the companies named on the label, are Mylan Pharmaceuticals Inc., Sandoz Inc. and Mylan Institutional Inc.
FDA’s Established Pharmacologic Class for it is Phenothiazine.
The NADAC file of 2026-10-14 prices it under 4 NDCs (National Drug Codes); the FDA directory lists 3 of them.
NADAC classes it as a generic drug (rate-setting class G), and does not mark it as sold over the counter.
What pharmacies pay
Pharmacies pay $25.80 for 30 tablets (30 × $0.86 per EA, rounded to the cent), by the CMS NADAC file of 2026-10-14; that price took effect on 2026-09-23. That is what pharmacies pay their suppliers, not what they charge you.
NADAC’s explanation code for it: 1, calculated from the most recently completed pharmacy survey.
What NADAC measures · Why 30 tablets · NADAC explanation codes
All 4 NDCs
- 00378-2405-01 · Mylan Pharmaceuticals Inc. · $0.86 per EA · eff. 2026-09-23 filed
- 00781-8034-01 · Sandoz Inc. · $0.86 per EA · eff. 2026-09-23 filed
- 51079-0574-01 · not listed as a package in the FDA directory · $0.86 per EA · eff. 2026-09-23 filed
- 51079-0574-20 · Mylan Institutional Inc. · $0.86 per EA · eff. 2026-09-23 filed
Other strengths, forms and brands
3 other products in the NADAC file share the FDA nonproprietary name trifluoperazine hydrochloride with TRIFLUOPERAZINE 5 MG TABLET.
| Product | Pharmacies pay per unit | Medicare per unit |
|---|---|---|
| TRIFLUOPERAZINE 1 MG TABLET | $0.42513 per EA filed | $0.83507 per EA filed |
| TRIFLUOPERAZINE 2 MG TABLET | $0.57869 per EA filed | $0.83507 per EA filed |
| TRIFLUOPERAZINE 5 MG TABLET this page | $0.86 per EA filed | $0.83507 per EA filed |
| TRIFLUOPERAZINE 10 MG TABLET | $1.24317 per EA filed | $0.83507 per EA filed |
Part D is one average per brand and generic name, over every strength and form.
CMS NADAC · nadac-national-average-drug-acquisition-cost-20261014.csv · eff. 2026-09-23 · as of 2026-10-14 · retrieved 2026-10-17
Medicare Part D · DSD_PTD_RY26_P04_V10_DY24_BGM.csv · eff. 2024-01-01 to 2024-12-31 · as of 2026-06-25 · retrieved 2026-10-18
Compared with its class
The middle of its 4 NDCs’ NADAC prices is $0.86 per EA filed.
Of the 32 other products in FDA’s Phenothiazine class priced per EA, 8 have a higher middle NADAC price and 24 a lower one. The one in the middle is CHLORPROMAZINE 50 MG TABLET, at $0.41446 per EA filed (eff. 2026-09-23).
Prices are compared per unit, whatever the strength or dose, and a class is not a list of substitutes.
CMS NADAC · nadac-national-average-drug-acquisition-cost-20261014.csv · eff. 2026-09-23 · as of 2026-10-14 · retrieved 2026-10-17
What Medicare paid
Medicare Part D paid $25.05 for 30 tablets, at an average of $0.83507 per EA in 2024 (2024-01-01 to 2024-12-31) for “Trifluoperazine HCl”, every strength and form sold under that name together (Medicare Part D Spending by Drug, file of 2026-06-25).
That average covers 37,157 Part D claims (fills, including refills) for 2024-01-01 to 2024-12-31, across every maker, strength and form under the name.
Medicare's price is not your price.
What Part D spending measures · Which Medicare figure OpenBill compares · How the spread is worked out
What to ask at the counter
None of these figures is your price: what you pay depends on your pharmacy, your insurance, coupons and discounts.
- What is your cash price for 30 tablets? Is it lower than what I would pay through my insurance?
- If you have Medicare Part D: what is my plan’s copay or coinsurance for it? The Part D average on this page is not what you pay.
- These are questions about price, not medical advice. Do not change or stop a medicine without talking to your prescriber or pharmacist.
Questions
- Why is the comparison with Medicare for TRIFLUOPERAZINE 5 MG TABLET labelled estimated?
- Beyond what the card shows, the records give these reasons: The Part D figure covers 2024-01-01 to 2024-12-31; the NADAC price is from the file of 2026-10-14. Part D spending basis, as the Part D record states it: Part D 2024 average spend per dosage unit for Trifluoperazine HCl / Trifluoperazine HCl: all makers, strengths, forms and routes combined, claim-weighted; gross cost incl. dispensing fees and patient pay, before rebates. Unit taken as NADAC's EA. Joined on generic name.
Related pages
Its pharmacologic class
Related in the same class
- CHLORPROMAZINE 10 MG TABLET
- FLUPHENAZINE 1 MG TABLET
- PERPHENAZINE 16 MG TABLET
- FLUPHENAZINE DEC 125 MG/5 ML
- THIORIDAZINE 10 MG TABLET